Insulet (PODD) Operating Expenses (2010 - 2026)

Insulet (PODD) has reported Operating Expenses for 17 consecutive years, with $432.9 million the latest figure, recorded in Q2 2026.

• For the quarter ending Q2 2026, Operating Expenses rose 30.75% year-over-year to $432.9 million; the trailing twelve-month figure through Jun 2026 stood at $1.7 billion (up 31.11% YoY), and the FY2025 full-year result was $1.5 billion, up 28.97% from the prior year.
• Operating Expenses climbed to $432.9 million in Q2 2026 per PODD's latest filing, from $406.9 million in the prior quarter.
• Across five years, Operating Expenses topped out at $432.9 million in Q2 2026 and bottomed at $171.8 million in Q1 2022.
• Historically, Operating Expenses has averaged $286.1 million across 5 years, with a median of $265.6 million in 2023.
• The sharpest annual moves came in 2022 and 2023: Operating Expenses soared 205.21% in 2022, then increased 7.74% in 2023.
• Over 5 years, Operating Expenses stood at $193.8 million in 2022, then jumped by 31.42% to $254.7 million in 2023, then rose by 26.23% to $321.5 million in 2024, then jumped by 31.35% to $422.3 million in 2025, then gained by 2.51% to $432.9 million in 2026.
• According to Business Quant data, Operating Expenses over the past three periods registered $432.9 million, $406.9 million, and $422.3 million for Q2 2026, Q1 2026, and Q4 2025 respectively.